Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up. The Danish drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback